Status:

UNKNOWN

Effectiveness of Home Based Early Intervention of Extremely Premature Infant by Parent

Lead Sponsor:

Samsung Medical Center

Conditions:

Preterm

Extreme Prematurity

Eligibility:

All Genders

Phase:

NA

Brief Summary

This study is to prove the effectiveness of home based early intervention of extremely premature infant by Parent.

Detailed Description

The perpose of this study to prove the significance of the hypothesis that there will be a significant improvement in motor development when remote tele-rehabilitation treatment is performed for extre...

Eligibility Criteria

Inclusion

  • Extreme premature baby (gestationl age 23\~28 weeks)
  • Corrected age under one month at the time of enroll of this study
  • Children of those who voluntarily decided to participate after hearing detailed explanations about this study and gave their written consent.
  • Children whose parents are Korean

Exclusion

  • Congenital anomalies in the central nervous system
  • Hereditary diseases
  • Chromosomal abnormalities (Down syndrome, etc.)
  • Stage 3 or more intraventricular hemorrhage
  • If surgery was performed for hydrocephalus
  • Leukomalacia confirmed by ultrasound examination (not applicable to increase in white matter shading)
  • Neonatal asphyxia
  • Other central nervous system diseases
  • If taking medications for convulsions or epilepsy
  • Metabolic disease
  • In the case of premature infants undergoing surgery for retinal disease
  • Hearing loss
  • In case of surgery due to complex congenital anomaly or planned operation (not excluded if surgery is not required)
  • In case of oxygen dependence due to lung disease in premature infants
  • Musculoskeletal disorders (hip dislocation, polyarthrosis, etc.)
  • Neuromuscular disease, etc.
  • Those whose family has social problems
  • Those whose parents cannot participate in this study
  • Those who have other serious complications that cannot proceed with the study

Key Trial Info

Start Date :

June 2 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 2 2024

Estimated Enrollment :

110 Patients enrolled

Trial Details

Trial ID

NCT05334550

Start Date

June 2 2022

End Date

March 2 2024

Last Update

June 8 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.